Staar Surgical (STAA) announced that independent proxy advisory firm Institutional Shareholder Services has issued a new report and revised its recommendation with respect to Staar’s merger with Alcon (ALC). ISS is now recommending that all Staar stockholders vote “FOR” Staar’s amended merger agreement with Alcon at Staar’s Special Meeting of Stockholders on December 19, 2025 at 8:30 a.m. (Pacific Time).
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA:
- Staar Surgical comments on ‘misinformation’ regarding go-shop process
- Staar Surgical shareholder issues statement on acquisition by Alcon
- Staar Surgical shareholder issues letter opposing Alcon merger
- Hold Rating Maintained Amidst Alcon-Staar Merger Developments and Valuation Considerations
- Staar Surgical price target raised to $30.75 from $28 at Wells Fargo